MTCYBP15

Across TCGA pan-cancer cohorts, MTCYBP15 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated MTCYBP15 data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher MTCYBP15 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MTCYBP15 expression acts as an unfavorable survival marker, although some lineages such as TGCT and BLCA show a favorable association.

UCS, STAD, and BRCA are the cancer types where MTCYBP15 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	OS	Tertile	All	0.230	0.695	.002	144	view →
STAD	DFS	Quartile	II,III,IV	0.456	0.743	.001	46	view →
BRCA	DFS	Tertile	II,III,IV	0.471	0.523	.010	42	view →
READ	DFS	Tertile	All	0.233	0.703	.002	39	view →
HNSC	OS	Tertile	III,IV	0.251	0.684	.005	39	view →
DLBC	OS	Tertile	III,IV	0.175	0.874	.025	36	view →
KIRC	DFS	Tertile	IV	0.137	0.639	.004	18	view →
UCEC	OS	Tertile	All	0.876	0.933	.009	18	view →
OV	DFS	Tertile	IV	0.231	0.481	.022	18	view →
TGCT	DFS	Quartile	All	0.982	0.778	.019	14	view →
BLCA	DFS	Tertile	III,IV	1.000	0.188	.035	9	view →
COAD	DFS	Tertile	All	1.000	0.775	.034	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

MTCYBP15–UCS (OS)

Open the UCS breakdown →